COMMUNIQUÉS West-GlobeNewswire

Kamada Received Feedback from FDA on Proposed Phase 3 Protocol for Inhaled Alpha-1-Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency Disease

23/04/2018 - 13:00

REHOVOT, Israel, April 23, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (the "Company") (Nasdaq: KMDA ) (TASE: KMDA ), a plasma-derived protein therapeutics company, today announced that the Company recently received feedback [...]

Zynerba Pharmaceuticals Announces Oral Presentation of ZYN002 Data at the 16th NFXF International Fragile X Conference in July 2018

23/04/2018 - 13:00

DEVON, Pa., April 23, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE ), a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative [...]

Aclaris Therapeutics Announces First Patient Dosed in a Pilot Study with ATI-502 Topical in Patients with Androgenetic Alopecia

23/04/2018 - 13:00

WAYNE, Pa., April 23, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to [...]

Summit Highlights Discovery of a Series of New Mechanism Antibiotics for the Treatment of Gonorrhoea in Late-Breaking Presentation at ECCMID 2018

23/04/2018 - 13:00

OXFORD, United Kingdom and CAMBRIDGE, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT ) (AIM:SUMM) announces it highlighted the discovery of new mechanism antibiotic candidates for the [...]

Pluristem and Indiana University to Initiate Joint Project Evaluating PLX-R18 in Acute Radiation Syndrome, Targeting Bridging Data for Pivotal Study

23/04/2018 - 13:00

The 5-year joint project was granted $2.5 million from the U.S. National Institutes of Health (NIH) Data from these studies will support BLA filing for marketing approval of PLX-R18 in the treatment of ARS HAIFA, Israel [...]

Axsome Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of AXS-05 in Smoking Cessation

23/04/2018 - 13:00

Trial being conducted in collaboration with Duke University NEW YORK, April 23, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM ), a clinical-stage biopharmaceutical company developing novel therapies [...]

Annual Report 2017 Active Biotech AB (publ)

23/04/2018 - 11:31

PRESS RELEASE Active Biotech's Annual Report 2017 is now available för download at www.activebiotech.com . The Annual Report will only be digitally distributed. The English version will be available within short. Lund, [...]

Transactions under Novozymes’ stock buyback program

23/04/2018 - 11:15

Please read the full announcement in the attached PDF Attachment 2018_15_Stock_Buybackprogram_EN

Q Therapeutics Announces Joint Venture With REPROCELL

23/04/2018 - 11:00

PARTNERSHIP WILL DEVELOP IPSC-DERIVED PRODUCTS TO TREAT CENTRAL NERVOUS SYSTEM DISEASES INVOLVING DEMYELINATION AND DEGENERATION SALT LAKE CITY andI YOKOHAMA, Japan, April 23, 2018 (GLOBE NEWSWIRE) -- Q Therapeutics, [...]

Amarin Announces Promotion of Aaron Berg to Position of Chief Commercial Officer

23/04/2018 - 11:00

BEDMINSTER, N.J., and DUBLIN, Ireland, April 23, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]

Share buy-back week 16/2018

23/04/2018 - 10:43

Announcement 23 April 2018 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up [...]

Notice of Annual General Meeting in Acarix AB

23/04/2018 - 10:01

Press release April 23, 2018 Notice of Annual General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the " Company "), are hereby convened to the annual general meeting to be held on [...]

Reminder: C-RAD Web Presentation Interim Report Q1 2018

23/04/2018 - 09:30

Presentation of the report for the first quarter of the fiscal year 2018: Date: Thursday April 26, 2018 / kl. 11:00 Venue: Online Presentation Topic: C-RAD Interim Report Q1 2018 Procedure: Please register online [...]

Acarix publishes the annual report for 2017

23/04/2018 - 08:01

Press release from Acarix AB (publ) 2018-04-23 Acarix publishes the annual report for 2017 Today, Monday April 23, Acarix is publishing its Annual Report for 2017 on the company website www.acarix.com . The Annual [...]

Shire plc : Rule 2.9 Announcement

23/04/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 23 April 2018 [...]

GENFIT : Positive Outcome from the 24-month Pre-Planned Safety Review by the DSMB, in RESOLVE-IT Phase 3 Clinical Trial with Elafibranor

23/04/2018 - 08:00

GENFIT: Positive Outcome from the 24-month Pre-Planned Safety Review by the DSMB, in RESOLVE-IT Phase 3 Clinical Trial with Elafibranor Safety data, including adverse events and laboratory data, were reviewed by the [...]

GENFIT : issue positive du DSMB suite à la revue planifiée à 24 mois des données de tolérance et de sécurité d'emploi d'elafibranor, dans l'étude clinique de Phase 3 RESOLVE-IT

23/04/2018 - 08:00

GENFIT : issue positive du DSMB suite à la revue planifiée à 24 mois des données de tolérance et de sécurité d'emploi d'elafibranor, dans l'étude clinique de Phase 3 RESOLVE-IT Les données de tolérance et de sécurité d' [...]

Lysogene Strengthens Board of Directors with Appointment of Dr. Peter Lichtlen

23/04/2018 - 08:00

CAMBRIDGE, Mass. and PARIS, April 23, 2018 (GLOBE NEWSWIRE) -- Lysogene (FR0013233475 – LYS), a leading biopharmaceutical company pioneering gene therapy technologies to treat central nervous system (CNS) diseases, [...]

Sensorion and Uconn Health Announce Identification of First Potential Biomarker for Noise-Induced Hearing Loss

23/04/2018 - 07:30

New study shows prestin in the blood following noise-induced trauma may be a biomarker for hearing loss MONTPELLIER, France, April 23, 2018 (GLOBE NEWSWIRE) -- New preclinical study findings presented at the 53 rd [...]